Earnings Feed
Start Free
Home/Filings/4/0001225208-15-011270
4//SEC Filing

Merck & Co., Inc. 4

Accession 0001225208-15-011270

$MRKCIK 0000310158operating
View on SEC.govCompany Profile

Filed

May 4, 8:00 PM ET

Accepted

May 5, 4:46 PM ET

Size

15.8 KB

Accession

0001225208-15-011270

Insider Transaction Report

Form 4
Period: 2015-05-01
Merck & Co., Inc.MRK
Kuhlik Bruce N
Exec. V.P. and General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2015-05-01+142,415→ 142,415 total
    Exercise: $59.86From: 2016-05-01Exp: 2025-04-30→ Common Stock (142,415 underlying)
  • Exercise/Conversion

    Common Stock

    2015-05-04$39.29/sh+56,064$2,202,755→ 206,496.143 total
  • Exercise/Conversion

    Common Stock

    2015-05-02+11,708→ 156,503.143 total
  • Tax Payment

    Common Stock

    2015-05-02$59.86/sh−6,071$363,410→ 150,432.143 total
  • Exercise/Conversion

    Restricted Stock Unit

    2015-05-02$59.86/sh−11,708$700,841→ 0 total
    From: 2015-05-02Exp: 2015-05-02→ Common Stock (11,708 underlying)
  • Sale

    Common Stock

    2015-05-04$60.20/sh−56,064$3,374,795→ 150,432.143 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2015-05-04−56,064→ 0 total
    Exercise: $39.29From: 2013-05-02Exp: 2022-05-01→ Common Stock (56,064 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0500 to $60.4200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.
  • [F3]The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F5]The option vested and became exercisable in three equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

→
Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000310158

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:46 PM ET
Size
15.8 KB
View on SEC.gov